Evidence map›Paper›PMID 41639292›Full record

ArticleScientific reports2026

Comparison of choroidal hypertransmission and retinal pigment epithelium loss for quantification of geographic atrophy across commonly used SD-OCT devices.

Anna Eidenberger, Klaudia Birner, Sophie Frank-Publig, Johannes Schrittwieser, Merle Tratnig-Frankl, Markus Gumpinger, Ursula Schmidt-Erfurth

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna EidenbergerDepartment of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
Klaudia BirnerDepartment of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
Sophie Frank-PubligDepartment of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
Johannes SchrittwieserDepartment of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
Merle Tratnig-FranklDepartment of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
Markus GumpingerLaboratory for Ophthalmic Image Analysis (OPTIMA), Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.
Ursula Schmidt-ErfurthLaboratory for Ophthalmic Image Analysis (OPTIMA), Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria. ursula.schmidt-erfurth@meduniwien.ac.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To compare the consistency of choroidal hypertransmission (HT) and retinal pigment epithelium (RPE) loss area measurements among three commonly used spectral-domain optical coherence tomography (OCT) devices and assess their robustness for monitoring of geographic atrophy (GA). Patients with GA were imaged during a single visit using the three different OCT: (1) Heidelberg Spectralis; (2) Zeiss Cirrus; (3) Topcon Maestro2. Expert readers manually annotated a total of 120 OCT volumes for RPE loss and HT. Dice similarity coefficients (DSC) were calculated to quantify the spatial overlap between the lesions within each OCT device. Intraclass correlation coefficients (ICC) and Bland-Altman analyses were used to assess inter-device agreement. Spatial overlap between HT and RPE loss ranged from moderate to good, with HT lesions being significantly larger than RPE loss areas across all devices (p < 0.001). Overall agreement was good for HT and RPE loss. Systematic biases emerged, with Cirrus yielding consistently smaller measurements compared to Spectralis or Maestro2. Lesion measurements demonstrated good agreement across all three OCT devices, yet device-dependent differences require caution when comparing data. Accounting for inter-device variability is an essential step toward reliable clinical endpoints and successful integration of automated OCT algorithms into clinical trials and routine AMD care.

Indexed as

ChoroidGeographic AtrophyRetinal Pigment EpitheliumTomography, Optical CoherenceAgedFemaleHumansMaleArtificial intelligenceDeep learningGeographic atrophyHypertransmissionOptical coherence tomographyRPE loss

Identifiers

PMID41639292
PMCPMC12923578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.